X

Rubriques :

Maroc

Maroc - MOUNTAINTODAY.IN - A La Une - 26/Jun 19:24

Biliary Tumor Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

DelveInsight’s, “Biliary Tumor Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Biliary Tumor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products.

Articles similaires

Sorry! Image not available at this time

Hepatic Tumor Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 26/Jun 19:28

DelveInsight’s, “Hepatic Tumor Pipeline Insight 2024”report provides comprehensive insights about 75+ companies and 75+...

Sorry! Image not available at this time

Endometrial Cancer Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 21/Jun 19:16

DelveInsight’s, “Endometrial Cancer Pipeline Insight 2024” report provides comprehensive insights about 50+ companies...

Sorry! Image not available at this time

Primary Biliary Cholangitis Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 21/Jun 19:24

DelveInsight’s, “Primary Biliary Cholangitis Pipeline Insight 2024” report provides comprehensive insights about 18+...

Sorry! Image not available at this time

Ulcerative Colitis Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 21/Jun 19:36

DelveInsight’s, “Ulcerative Colitis Pipeline Insight 2024” report provides comprehensive insights about 70+ companies...

Sorry! Image not available at this time

Peritoneal Cancer Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 26/Jun 19:12

DelveInsight’s, “Peritoneal Cancer Pipeline Insight 2024” report provides comprehensive insights about 55+ companies...

Sorry! Image not available at this time

Pneumococcal Pneumonia Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 21/Jun 19:28

DelveInsight’s, “Pneumonia, Pneumococcal Pipeline Insight 2024” report provides comprehensive insights about 12+...

Sorry! Image not available at this time

Advanced Non-Squamous & Squamous NSCLC Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 21/Jun 19:12

DelveInsight’s, “Advanced Non-Squamous & Squamous NSCLC Pipeline Insight, 2024,” report provides comprehensive...

Sorry! Image not available at this time

PD-1 Non-Small Cell Lung Cancer Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 26/Jun 19:16

DelveInsight’s, “PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) Pipeline Insight 2024” report provides comprehensive...

Sorry! Image not available at this time

Polycystic Ovarian Syndrome Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Sanofi, Novartis, Teva Pharma, Addex Therapeutics

mountaintoday.in - 20/Jun 09:56

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Polycystic Ovarian Syndrome pipeline constitutes 4+ key companies...

Sorry! Image not available at this time

Clostridium Difficile Infections Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight

mountaintoday.in - 28/Jun 16:52

Clostridium Difficile Infections Pipeline Clostridium Difficile Infections companies are Vedanta Biosciences, Adiso Therapeutics, Finch Therapeutics...

Les derniers communiqués

Aucun élément